Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
maxidex augentropfensuspension
novartis pharma schweiz ag - dexamethasonum - augentropfensuspension - dexamethasonum 1 mg, conserv.: benzalkonii chloridum, excipiens a sospensione, per 1 ml. - non infetto infiammazione agli occhi - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
maxidex augentropfensuspension
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
maxidex augentropfensuspension
Unione Europea -
italiano -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - blocco neuromuscolare - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
Unione Europea -
italiano -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - blocco neuromuscolare - tutti gli altri prodotti terapeutici - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Unione Europea -
italiano -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - blocco neuromuscolare - tutti gli altri prodotti terapeutici - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Unione Europea -
italiano -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - blocco neuromuscolare - tutti gli altri prodotti terapeutici - inversione del blocco neuromuscolare indotto da rocuronio o vecuronio. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Unione Europea -
italiano -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - blocco neuromuscolare - tutti gli altri prodotti terapeutici - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
sugammadex zentiva
zentiva italia s.r.l. - sugammadex - sugammadex
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
sugammadex dr. reddy's
dr. reddy's s.r.l. - sugammadex - sugammadex